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Summary
To see whether age-related changes in bone could predict
subsequent lifespan, we measured multiple aspects of
femur size and shape at 4, 15, and 24 months of age in
genetically heterogeneous mice. Mice whose cortical
bone became thicker from 4 to 15 months, associated
with preservation of the endosteal perimeter, survived
longer than mice whose endosteal cavity expanded, at
the expense of cortical bone, over this age range. Femur
size at age 4 months was also associated with a difference
in life expectancy: mice with larger bones (measured by
length, cortical thickness, or periosteal perimeter) had
shorter lifespans. Femur length, midlife change in cortical
bone thickness, and midlife values of CD8 T memory cells
each added significant power for longevity prediction.
Mice in the upper half of the population for each of these
three endpoints lived, on average, 103 days (12%) longer
than mice with the opposite characteristics. Thus, mea-
sures of young adult bone dimensions, changes as a result
of bone remodeling in middle age, and immunological
maturation provide partially independent indices of
aging processes that together help to determine lifespan
in genetically heterogeneous mice.
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Introduction
Studies in rodents and humans have documented thousands of
traits that change with age in adult life, but have been notably
less successful (Sprott, 1999; Miller, 2001a; Johnson, 2006) in
providing evidence of early and midlife traits that can predict the
length of healthy lifespan and the rate of aging. Many studies
have documented risk factors for specific late-life diseases and
assessment of obesity, glucose tolerance, hypertension, and his-
tory of previous infarction, hip fracture, or neoplasia are rou-
tinely incorporated into clinical practice on the basis of their
predictive power. In contrast, studies of how lifespan can be
influenced by early developmental processes, and midlife rates
of change, are difficult to conduct in a species with a mean life-
span over 70 years. Although the shorter lifespan of rodents has
the potential to speed up such assessments, they depend upon
the development of methods that can assess relevant physiologi-
cal traits, preferably at several points over the life course, with-
out harm to the mouse.
The availability of in vivo micro-CT instrumentation that can
provide accurate assessments of mouse bone dimensions and
mineral content provided an opportunity to assess whether early
and midlife variation in bone properties could predict longevity.
We have conducted a longitudinal study using 519 mice, bred
by a four-way cross scheme (Jackson et al., 1999; Volkman
et al., 2003) so that the population would be molded by both
genetic and nongenetic influences. We chose to use this hetero-
geneous population, called ‘UM-HET3,’ for this study for several
reasons. UM-HET3 mice have been used in several previous stud-
ies (Volkman et al., 2003, 2004; Reeves et al., 2007) to map
genes related to the morphology and mechanical properties of
the femur and the vertebrae, thus providing a good deal of prior
information about bone biology on which to base our experi-
mental design and with which to compare our current results.
Secondly, we have also used UM-HET3 mice for several previous
studies of phenotypes that are predictive of lifespan and have
shown that both body size (Miller et al., 2002) and midlife T-cell
subset patterns (Miller & Chrisp, 2002; Harper et al., 2004) can
predict lifespan of individual animals. Thus, we selected the
UM-HET3 population for an analysis of whether changes in bone
morphology at various stages of adult life have implications for
lifespan. We also hope that observations made using genetically
heterogeneous populations may have broader applicability,
both for experimental animals and for human biology, than
studies based on mice of a single, potentially idiosyncratic geno-
type (Miller et al., 1999). Lastly, we were aware that the NIA has
selected the UM-HET3 population for its Intervention Testing
Program (Miller et al., 2007) and therefore believe that informa-
tion about bone development in aging UM-HET3 mice can serve
as a foundation for studies of anti-aging drugs and their possible
effects on bones.
We report that measurements of the rate of midlife change in
endosteal perimeter and cortical thickness of the femur predict
subsequent longevity, and that measurements of femoral size at
4 months provide additional, independent, predictive power.
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Measures of femur size, endosteal preservation, and an age-sen-
sitive T-cell subset can separate mice into groups that differ by
12% in median lifespan.
Results
Among the 519 mice evaluated, 10% died prior to 656 days,
median survival was 880 days, and 90% died prior to
1061 days. The oldest mouse survived to 1296 days. Measure-
ments taken at 15 and 24 months correspond to ages at which
survival was, respectively, 99% and 80% among the 519 mice
with bone data and recorded ages at death. Thus, values mea-
sured on mice at 24 months of age may not be representative
on the entire test population, but only on the 80% that survived
as long as 2 years.
Tests for femur length, cross-sectional area, cortical thickness,
periosteal perimeter, endosteal perimeter, and bone mineral
content were recorded at 4 months of age for 519 mice whose
date of death was subsequently recorded. Table 1 presents the
mean levels (with sem) for each of these endpoints. Cox regres-
sion calculations were used to determine which of these charac-
teristics was associated with differences in survival and mortality
risk, and Table 1 shows the hazard ratios (HR) and P-values for
each trait. High values of length, cross-sectional area, cortical
thickness, periosteal perimeter, and bone mineral content were
all associated with shorter lifespan, with unadjusted P-values
ranging from P = 0.003 for bone mineral content to P < 0.001
for length and cross-sectional area. Each of these measures is
positively correlated with each of the others, with regression
coefficients ranging from 0.36 to 0.91, and each is a measure of
femur size or robustness. A principal factors calculation (not
shown) showed that the first principal factor had positive load-
ings on each of these endpoints (0.5 for length and > 0.8 for all
other measures), and an eigenvalue of 3.5. In a Cox regression
model, this first principal factor was significantly associated with
mortality risk (HR = 1.18, P < 0.001). We conclude that mice
with larger femurs have elevated mortality risk after age
4 months.
The pattern of associations between bone traits and longevity
is altered, however, in mice tested at 15 months. Mean levels
for each trait are shown in Table 1, for each of the 505 mice that
survived to be tested in middle age. Of the five traits that were,
at 4 months of age, predictors of survival, only length is still a
significant predictor when measured at 15 months (HR = 1.4,
P = 0.005). Endosteal diameter, which was not associated with
lifespan when measured in 4 month old mice, is a significant
predictor measured in 15-month-old animals (HR = 1.7,
P < 0.001). High endosteal diameter values identify mice with
shorter life expectancy.
Table 1 also shows mean values for each of these traits mea-
sured in 24-month-old mice; 416 mice survived to be tested at
this age. Although high values of cortical thickness were associ-
ated with low life expectancy at 4 months (at P = 0.003), high
cortical thickness levels were associated with significantly
greater life expectancy (P = 0.005) when measured in mice at
24 months of age, a reversal of the direction of the association.
A similar reversal was seen for cross-sectional area, with high
levels associated with shorter lifespan at 4 months (P < 0.001),
but with a trend toward association of longer lifespan to lower
levels (P = 0.08, not significant) when cross-sectional area is
measured in 24-month-old animals. The association between
good survival and low endosteal perimeter levels, seen at
15 months of age, is even stronger at 24 months of age (Cox
regression HR of 1.7 and 2.2, respectively).
Table 2 shows an alternate approach to evaluating inter-
mouse differences in bone aging and mortality risks. For each
trait, we calculated a change score by subtracting the 4-month
value from the 15-month value for each of the 449 mice that
were measured at each age. Mean values of these change
scores are shown in Table 2, and each was significantly different
Table 1 Mean values for bone traits and results of univariate cox regression analyses
Variable
Age = 4 months (N = 519) Age = 15 months (N = 505) Age = 24 months (N = 416)
Mean ± SEM
HR
P-value Mean ± SEM
HR
P-value Mean ± SEM
HR
P-value
Length 15.9 ± 0.02 1.5
0.001fl
16.6 ± 0.02 1.4
0.005fl
16.6 ± 0.03 1.2
0.13
Cross-sectional area 1.11 ± 0.006 3.3
0.001fl
1.31 ± 0.007 0.89
0.7
1.40 ± 0.01 0.65
0.08›
Cortical thickness 0.32 ± 0.002 41
0.003fl
0.34 ± 0.002 0.17
0.1
0.34 ± 0.003 0.06
0.005›
Periosteal perimeter 4.88 ± 0.013 1.5
0.007fl
5.34 ± 0.02 1.2
0.2
5.66 ± 0.02 1.2
0.15
Endosteal perimeter 2.94 ± 0.009 1.2
0.45
3.22 ± 0.01 1.7
0.001fl
3.58 ± 0.02 2.2
0.001fl
Bone mineral content 3.22 ± 0.021 1.3
0.003fl
3.93 ± 0.024 0.9
0.4
4.31 ± 0.03 0.9
0.5
SEM, standard error of the mean; HR, hazard ratio from Cox regression; N, number of mice evaluated at the indicated age. Up arrow › indicates that high
values are associated with improved life expectancy. Down arrow fl indicates that low values are associated with improved life expectancy. P-values are
nominal, i.e. they have not been adjusted for multiple comparisons.
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from zero (the null hypothesis) at P < 0.0001. We conclude that
each of these bone traits is sensitive to age, between 4 and
15 months, in these genetically heterogeneous mice. Four of
these change scores are significant predictors of remaining life-
span in Cox regression analyses (Table 2). Lower mortality risks,
and thus longest lifespans, are seen in 15-month-old mice that
exhibit the largest changes in cross-sectional area, cortical thick-
ness, and bone mineral content, and with the smallest change in
endosteal perimeter.
We calculated a similar set of change scores to evaluate
changes between 15 and 24 months of age, for the 369 mice
that were evaluated at each age (Table 2). Each of these change
scores is significantly different from zero at P < 0.0001, except
for cortical thickness (P = 0.08 for change score); this is consis-
tent with the idea that length, cross-sectional area, periosteal
perimeter, endosteal perimeter, and bone mineral content con-
tinue to increase between 15 and 24 months of age, although
interpretation of these values is complicated by the absence of
information on the 20% of mice that died prior to 24 months.
Among mice that survived to 24 months, high rates of change
in endosteal perimeter are again associated with lower remain-
ing life expectancy, as noted for changes between 4 and
15 months of age. None of the other change scores from 15 to
24 months was significantly associated with subsequent mortal-
ity risk. Figure 1 shows scatterplots relating lifespan to cortical
thickness change scores and endosteal perimeter change scores,
from 4 to 15 months, among individual mice. Those mice whose
cortical thickness declines from 4 to 15 months (cortical thick-
ness change score < 0) tend to die at earlier ages than those
whose cortical thickness values are above zero. Similarly, mice
that have the largest increase in endosteal perimeter in this age
range (high endosteal perimeter change scores) tend to die at
early ages compared to mice whose endosteal perimeter does
not change or decreases in midlife.
Table 2 Change scores for bone traits and results of cox regression analyses
Variable
Change score (1) [15 months ) 4 months]
N = 449




P-value Mean ± SEM
HR
P-value
Length 0.71 ± 0.01 0.99
0.9
0.05 ± 0.01 0.7
0.2
Cross-sectional area 0.21 ± 0.01 0.4
0.005
0.09 ± 0.01 0.7
0.2
Cortical thickness 0.023 ± 0.002 0.02
0.001
)0.004 ± 0.002 0.2
0.2
Periosteal perimeter 0.48 ± 0.01 0.90
0.5
0.33 ± 0.01 1.2
0.4
Endosteal perimeter 0.28 ± 0.01 1.9
0.003fl
0.37 ± 0.01 2.2
0.003fl
Bone mineral content 0.73 ± 0.03 0.81
0.01
0.39 ± 0.03 1.0
0.7
Change score is calculated as the value at the older age minus the value at the younger age in the same animal. SEM = standard error of the mean. Each
change score is significantly different from zero at P < 0.0001. HR, hazard ratio from Cox regression using the change score as independent variable.
N = number of mice evaluated at the indicated age. Up arrow indicates that high change scores are associated with improved life expectancy. Down arrow
fl indicates that low change scores are associated with improved life expectancy. P-values are nominal, i.e. they have not been adjusted for multiple
comparisons.
Fig. 1 Longer lifespan in mice with increase in cortical bone thickness and preservation of endosteal perimeter between 4 and 15 months of age. Each symbol
represents an individual mouse. Lines shown are least-squares regression, each P < 0.05.
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The analyses mentioned previously suggested that bone traits
were associated with survival in two ways: (i) small femurs in
4-month-old mice were predictive of better survival and (ii) pres-
ervation or increase in femur cortical thickness in midlife was pre-
dictive of better survival. To see whether these two sets of
changes provided independent predictive power, we evaluated a
series of bivariate Cox regression models, each combining a mea-
sure of bone size at 4 months with an index of change between 4
and 15 months. The strongest association (evaluated by likeli-
hood ratio v2) was for the combination of length at 4 months
and the cortical thickness change score. Length was associated
with a hazard ratio of 1.37 (P = 0.005) and cortical thickness
change score with a hazard ratio of 0.03 (P = 0.002). Figure 2
provides an illustration of the survival patterns for subsets of mice
distinguished by one or both of these predictors. Mice divided
into two groups on the basis of length at 4 months (left panel)
differ by 47 days in median survival (P = 0.001 by log-rank test
comparing mice with high or low levels of length). Cortical thick-
ness change score, by itself, divides mice into two groups that dif-
fer by 28 days in median lifespan (not shown). The middle panel
of Fig. 2 compares survival curves for mice that are in the lower
half for length and also in the upper half for cortical thickness
change score to those with the opposite category for both traits.
Mice with low levels of length (4) and high levels of the cortical
thickness change score live on average 78 days longer than mice
with the opposite phenotype (see Fig. 2, middle panel).
Prediction of lifespan by a combination of bone and
immune predictors
Studies of earlier populations of UM-HET3 mice had shown that
mice with elevated levels of memory T cells, at 18 months of
age, had shorter lifespans than mice with lower memory T-cell
fractions (Harper et al., 2004). We therefore thought it would
be of interest to discover whether the two classes of predictor
variables, i.e. immune and bone endpoints, would provide inde-
pendent predictive power in Cox regression models. In the cur-
rent group of UM-HET3 mice, the fraction of CD8 cells with the
memory phenotype (CD8M), measured at 18 months of age,
was again associated with differences in remaining lifespan
(HR = 1.01; P = 0.002 by Cox regression). Populations divided
by the median level of CD8M differed by 36 days in their median
survival (not shown). To see whether this measure of age-sensi-
tive immune status provided additional predictive power beyond
that available from bone traits alone, we performed a Cox
regression that included length (at 4 months), cortical thickness
change score (from 4 to 15 months), and CD8M levels (at
18 months). Table 3 shows the results of the regression calcula-
tion. Each of these traits added significant power to the overall
regression at 0.01 < P < 0.03. Each individual measurement
can divide the population into halves that differ by 47, 28, or
36 days in median lifespan. When mice are classified on all three
indices, however, those with the optimal combination (short
Fig. 2 Survival plots for subpopulations of mice differing in combinations of bone and immune traits. Left: populations of mice in the top or bottom half of the
distribution for femoral length at 4 months of age. Middle: circles indicate mice that were in the bottom half of the distribution for femur length at 4 mon and also
in the top half of the cortical thickness change score distribution (15 ) 4 mon). Triangles indicate mice in top half of the femur length distribution and the bottom
half of the cortical thickness change score listing. Right: as for the middle panel, with the additional criterion based on the CD8 memory cell median score. P-values
calculated by log-rank test comparing the two survival distributions illustrated.
Table 3 Cox regression for a model combining bone and immune predictors of lifespan
Model Hazard ratio P-values Effect sizes (univariate) Effect size (days) (overall model)
Length (4) 1.33 0.02 47 103
Cortical thickness (Change) 0.06 0.01 28
CD8M (18) 1.009 0.03 36
Hazard ratios and associated P-values for a Cox regression model with three predictors: Length at 4 months, cortical thickness change score from 4 to
15 months, and CD8 memory cell value at 18 months. Effect size (univariate) indicates difference in median lifespan between mice in the top or bottom half
of the distribution for each predictor variable considered separately. Right-hand column gives difference in median lifespan between mice with above or
below the median values for each of the three predictors and corresponds to the survival curve shown in Fig. 2 (right panel).
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femur length at 4 months, greatest change in cortical thickness
between 4 and 15 months, and lowest number of CD8 memory
cells at 18 months) have a median survival that is 103 days
longer than the group with the opposite set of traits. This value
is 12% of the median lifespan for the population as a whole.
The right panel of Fig. 2 shows survival curves for these two
mouse subpopulations.
The Wang-Allison method (Wang et al., 2004) was used to
evaluate differences between these subpopulations in extreme
survival. The two subpopulations shown in Fig. 2 (right panel)
had a joint survival distribution for which only 10% of the mice
lived more than 1074 days. At this age, 3 ⁄ 68 (4%) mice in the
shorter-lived population still survived, compared to 10 ⁄ 60
(17%) of the longer-lived group; this difference is significant at
P = 0.022 by Fisher’s exact test. We conclude that a combina-
tion of bone and immune predictors can divide the population
into subsets that differ in maximal lifespan.
Correlation between immune and bone predictors
Lastly, we evaluated the question of whether mice that preserve
femoral bone in midlife also preserve youthful immune status, a
hypothesis consistent with the idea that each of these indices
provides information about inter-mouse differences in rate of
aging. Mice with low levels of CD8M were indeed found to have
relatively high levels of cortical thickness change score
(R = )0.1, P = 0.03) and low levels of endosteal perimeter
(measured at 15 months) (R = 0.12, P = 0.01). Both relation-
ships are in the predicted direction, in that mice with youthful
CD8M levels also have values for endosteal perimeter and corti-
cal thickness change scores that are associated with longer sur-
vival. The association is in each case statistically significant, but
small in size.
Discussion
Micro-CT methods now permit serial assessment of bone geom-
etry in individual mice as they age. We have shown here that
measurements of bone size and shape can predict mouse life-
span at ages well below the median age at death. The spectrum
of traits that have predictive value changes with age: for some
traits, like cortical thickness, high values can be predictive of lon-
gevity at one age and low values at other ages. We found that
combinations of bone measures and age-sensitive immune end-
points can divide the population into subsets that differ in med-
ian lifespan by as much as 100 days, with significant difference
in maximal lifespan. The study was conducted in genetically het-
erogeneous mice to provide sources of both genetic and nonge-
netic differences and to facilitate a later search for genetic
polymorphisms relevant to bone aging and mouse longevity.
Traits that predict life expectancy can, in principle, emerge
from at least three categories, each with its own implications for
biology of bone development, disease risk, and aging.
1. Some traits may serve as indicators of risk of specific lethal
illnesses; these are the classical ‘risk factors.’ Head trauma, for
example, is a well-known risk factor for some forms of human
neurodegenerative disease, just as are inherited alleles for Hun-
tington’s disease. In the area of bone biology, a malformed ace-
tabulum is an important risk factor, in Labrador Retrievers, for
late-life hip arthritis, often serious enough to require humane
euthanasia of the animal. Disease-specific risk factors of this
kind do not provide useful information about the biology of the
aging process and its regulation, despite their importance as
clues to the risk, and in some cases the pathogenesis, of impor-
tant and potentially fatal illnesses.
2. A second class of predictors consists of traits that may
indeed be closely related to inter-individual differences in aging,
regardless of the effects of aging on the trait itself. Among dogs,
Fig. 3 The overall whole-bone femoral length was calculated from
thresholded microCT images. Geometric analyses were performed on a
standardized 3-mm mid-diaphyseal segment within the left femora. Cross-
sectional area, cortical thickness, and periosteal and endosteal perimeters
were measured at 4, 15, and 24 months.
Table 4 Summary of bone measurements used for this study
Trait (units) Description
Length (mm) Whole bone femoral length
Cross-sectional area (mm2) Average cortical bone area of a cross section within the diaphyseal region of interest
Cortical thickness (mm) Average thickness of femoral cortex around circumference of bone within the diaphyseal region of interest
Endosteal perimeter (mm) Perimeter of the inner surface of the cortex (endosteum) within the diaphyseal region of interest
Periosteal perimeter (mm) Perimeter of the outer surface of the cortex (periosteum) within the diaphyseal region of interest
Bone mineral content (mg cc)1) Mineral content of the bone within the diaphyseal region of interest
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for example, smaller purebred dogs tend to live much longer
than dogs of larger breeds (Li et al., 1996; Michell, 1999), and
small stature is also associated with longer lifespan among non-
purebred dogs (Patronek et al., 1997). Similarly, short stature in
humans is associated with a dramatic reduction in risk of most
forms of neoplasia (Albanes et al., 1988; Tretli, 1989; Hebert
et al., 1993; Tretli & Robsahm, 1999; Davey et al., 2000; Petrelli
et al., 2002). The association between short stature and
increased longevity in dogs is associated with, and presumably
reflects, resistance of shorter dogs to many forms of illness,
including cataracts (Williams et al., 2004), lethal cardiovascular,
neurological, and neoplastic disease (Bonnett et al., 2005), and
other geriatric complaints (Hoskins & McCurnin, 1997). Small
body size is also associated with higher life expectancy among
related breeds of mice (Miller et al., 2000) and among individual
mice of the UM-HET3 stock (Miller et al., 2002). It is plausible,
though not proven, that some of the differences among mouse
stocks, mice, and dog breeds in life expectancy might represent
effects of growth hormone and ⁄ or IGF-1, in that single-gene
mutations that inhibit growth hormone (GH) and IGF-1 signals
often lead to improved longevity in mice (Brown-Borg et al.,
1996; Coschigano et al., 2000; Flurkey et al., 2001), as well as
to postponement of many of the lethal and nonlethal conse-
quences of aging (Flurkey and Harrison, 1990; Kinney et al.,
2001; Ikeno et al., 2003; Vergara et al., 2004). Differences
among individuals, or breeds, in body stature or in underlying
GH ⁄ IGF levels (Eigenmann et al., 1984), may lead to differences
in aging rate and thus modulate incidence and severity of a wide
range of age-related traits and diseases, whether or not size and
hormone levels change systematically with age. Measurements
of bone size and robustness, taken early in adult life, fall into this
category.
3. The third class of predictors, conceptually, might represent
variables that are age-sensitive in adults, and whose pace of
change in adult life can serve as a surrogate for the pace of the
underlying aging process (Miller, 2001a). Such predictors can be
considered ‘biomarkers’ of aging, in the same sense that blood
alcohol level can be considered a biomarker for recent consump-
tion of alcoholic beverages, i.e. as an easily measurable index of
an unobserved process (aging or drinking). It is easy to construct
a set of biomarkers that distinguish long-lived from short-lived
dog breeds: an individual dog that reaches age 6 or 8 years
without any evidence of cataract, arthritis, anosmia, presbycusis,
or cardiovascular decline can be considered to be aging more
slowly than a dog with problems in most of these age-sensitive
systems. Biomarkers of aging, like risk factors for disease, may
well be associated statistically with altered life expectancy, but
are also expected to have predictive power for a wide range of
age-sensitive traits unrelated to specific lethal illnesses. It has
been remarkably difficult to validate biomarkers of aging that
are distinct from disease-specific risk factors (class 1) and from
surrogates for processes that control aging rate (class 2).
We believe that the bone traits listed in Table 1 include repre-
sentatives of two of these three classes. The measurements
taken at age 4 months reflect, we think, different estimators of
overall robustness and size; these are all correlated with one
another and are all associated with lifespan in the same direc-
tion. Long femur length, large cross-sectional area, thick cortical
bone, long periosteal diameter, and high bone mineral content
are all seen in mice destined for relatively short lives. The ability
of these measures, taken at 4 months of age, to predict life
expectancy seems likely to represent the influence of some
underlying physiological factor, possibly related to the GH ⁄ IGF-1
axis, with effects on both aging and bone morphology.
The predictive factors that attain significance only in midlife,
however, may well be of another type, class 3, i.e. biomarkers of
the pace of aging. In 15-month-old mice, those with the largest
periosteal diameters have the shortest life expectancy, and by
24 months, high values for cortical bone thickness, originally
associated with poor survival, are now significantly associated
with higher life expectancy. Measures of cross-sectional area
show a similar pattern: a negative association with survival when
measured at 4 months and a positive (although not significant
at P = 0.08) association at the 24-month time point. All three of
these measures provide related information about the size of
the marrow cavity, the thickness of the remaining cortical bone,
and the relative ability of bone-forming process in the interior of
the femur to keep pace with bone resorption. Thus, optimal sur-
vival is seen in mice that have relatively small femurs when
young (low values for cortical thickness, cross-sectional area,
and periosteal perimeter as well as length), but which retain as
much bone thickness as possible at oldest ages and thus have
relatively high values for cortical thickness and low values for
endosteal perimeter. The bivariate regression analysis shows
that measurements sensitive to bone remodeling between 4
and 15 months of age add predictive power beyond models that
rely only on indices of bone size at age 4 months.
Neither variety of bone measurement is a plausible candidate
for a risk factor for lethal disease in UM-HET3 mice. Terminal
necropsies have been reported for 886 UM-HET3 mice (Lipman
et al., 2004), including 344 virgin females. Most of these mice
die of neoplasms, including fibrosarcoma, hemangiosarcoma,
lymphoma, and pulmonary adenocarcinoma. Nonneoplastic ill-
nesses can account for death in about 6% of the virgin females.
It seems very unlikely that inter-animal differences either in bone
size, or in midlife bone remodeling, contribute to the risk of
these terminal illnesses. We therefore favor the hypothesis that
differences in the pace at which cortical bone thickness is lost
(and endosteal perimeter increased) are related to differences
among the mice in the rate of aging, which in turn affects risks
and severity of lethal diseases in these animals.
Our data show a correlation between the rate of bone remod-
eling and survival in mice. There appear to be two distinct varie-
ties of bone remodeling, likely to differ in their mode of
regulation and their functional consequences. The first is tar-
geted remodeling, a mechanism to respond to the need for
maintaining mechanical integrity, including the repair of micro-
damage in humans. The second is stochastic remodeling, associ-
ated with metabolic homeostasis, providing access to stored
chemical constituents such as calcium (Burr & Martin, 1993; Han
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et al., 1997; Parfitt, 2002). Stochastic remodeling is regulated
by hormones and a variety of growth factors, while targeted
remodeling has been reported as a response to osteocyte apop-
tosis (resulting from microdamage and continued mechanical
usage), habitual mechanical demand, and changes in the extra-
cellular matrix with advanced age (Burr, 2002; Heaney, 2003;
Noble, 2003; Waldorff et al., 2010). Independent of the remod-
eling mechanism, however, it has been proposed that the local
process of remodeling results in a local net loss in bone volume
(Parfitt, 2002). This proposed loss of bone with remodeling, sup-
ported by histological observations, occurs despite the tight cou-
pling known to exist between bone resorption and formation.
As a result, a substantial increase in remodeling rate has been
correlated to an increase in bone loss. This phenomenon is par-
ticularly apparent in the dramatic increase in rate of bone loss in
human females during the peri- and postmenopausal years. Sim-
ilar loss of bone is observed in mouse models of estrogen defi-
ciency as a result of ovariectomy (Alexander et al., 2001;
Bouxsein et al., 2005). Interestingly, the rate or extent of bone
loss because of decrease in estrogen has been observed to be
species specific and is hypothesized to be partly genetically regu-
lated (Iwaniec et al., 2006). Within the context of this paper, the
maintenance of cortical thickness and endosteal diameter in
longer-lived mice suggests that a slower pace of remodeling is
associated with survival, and that the rate of age-related bone
change may be controlled by processes that also influence the
age of occurrence of other late-life illnesses, including those that
lead to death in UM-HET3 mice. It is important to clarify this per-
spective and hypothesis. The observed changes to bone on the
endosteal and periosteal surfaces might also be considered a
modeling drift, as they may be occurring independently on dif-
ferent surfaces. Considering the advanced age of the mice,
however, we suspect that these findings are, in fact, a result of a
variation in remodeling occurring on both the endosteal and
periosteal surfaces. This proposed bone remodeling is likely to
reflect interactions among many regulatory pathways, including
changes in hormones and hormonal receptors, damage resis-
tance in the extracellular matrix, osteocyte resistance to apopto-
sis, and factors that influence signaling for osteoclastogenesis
and stem cell differentiation. Clearly, these provide valuable ave-
nues for future investigation, as well as the need to verify
whether the observations are a result of remodeling or a model-
ing drift.
Inter-animal variation in the levels of CD8 memory T cells (as a
proportion of CD8 T cells) provides additional predictive power
when added to regression models that include femur length,
retained cortical bone thickness, or both bone variables. We
have shown previously that age-sensitive T-cell subsets (Miller
et al., 1997; Miller, 2001b; Miller & Chrisp, 2002; Harper et al.,
2004), including memory cells of the CD4 and CD8 lineages, in
both spleen and blood, can predict lifespan in genetically heter-
ogeneous mice. In the current population, the CD8M subset has
independent predictive value in regression models that already
contain both kinds of bone information. When the mice are
divided into subsets distinguished by the median values of all
three predictors, the 1 ⁄ 8th of the mice with the most favorable
combination has a median life expectancy more than 100 days
above that of the 1 ⁄ 8th of the mice with the opposite set of pre-
dictors and differs significantly in a surrogate for maximal life-
span [the Wang-Allison test (Wang et al., 2004)]. The simplest
interpretation is that the factors that modulate age-dependent
T-cell changes are at least in part distinct from those that influ-
ence early and midlife variation in femoral bone.
The challenge of finding mid-life endpoints that can serve as
surrogate markers for differences in rate of aging, so easy to
meet in studies across species and across breeds of long-lived vs.
short-lived dogs, is still a live issue in rodent and human bioger-
ontology. Further developments in this domain would help
address the theoretical issue of whether individual mice, or indi-
vidual people, do in fact age at varying rates and at the same
time provide a practical tool for screening putative anti-aging
drugs to find candidates for further detailed and costly analyses.
Experimental procedures
Mice
Genetically heterogeneous mice were produced by a cross
between (C57BL ⁄ 6J · BALB ⁄ cJ)F1 males and (C3H ⁄ HeJ ·
DBA ⁄ 2J)F1 females. Mice of this variety are called UM-HET3 in
previous publications and have been used to document genetic
polymorphisms that control femoral and vertebral dimensions,
and mechanical fragility in 18-month-old mice (Volkman et al.,
2003, 2004; Reeves et al., 2007), as well as genetic variation
relevant to immune aging (Jackson et al., 1999; Miller et al.,
2003), and for the evaluation of immunological predictors of
lifespan (Miller et al., 1997; Miller & Chrisp, 2002). With respect
to nuclear genes, each mouse in the population can be consid-
ered a full sib of each other mouse, sharing a random 50% of its
genetic inheritance. This study used only female mice, bred over
a period of 24 months, housed in groups of four mice per cage,
and given free access to water and mouse chow. The colony
was evaluated every 3 months to document its specific-patho-
gen-free status as previously described (Miller et al., 2007); all
such tests were negative throughout the experiments reported
here. In addition to the bone assessments described later, each
mouse was subjected to a tail-tip biopsy for genotyping (to be
reported elsewhere) and subjected to tail venipuncture at
18 months to provide blood for T-cell evaluation. Mice were
inspected daily for general health, and age at death was
recorded for those found dead. Mice found to be extremely ill
were euthanized if, in the judgment of an experienced care-
taker, they were thought unlikely to survive more than another
day; in these cases, the date of euthanasia was used to calculate
age at death.
The experimental population initially consisted of 600 mice.
Fifteen of these died prior to 1 year of age, and because of tech-
nical errors, no age at death was recorded for three others. Of
the remaining 582 mice, 567 had died by the date of analysis,
and 15 (3%) were still alive (right censored in Cox regression
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analyses). Of these, 519 mice had micro-CT scans at 4 months
of age, and the analysis is thus based on assessment of these
519 animals.
MicroCT
Mice were placed into an induction chamber of 2–5% isoflurane
gas (MWI Veterinary Supply). Once the mice were fully anesthe-
tized, they were positioned and secured in the prone position on
the scanning bed and maintained on 2% isoflurane gas through
a nose cone throughout the imaging. The mice were imaged at
4, 15, and 24 months of age using an eXplore Locus in-vivo
micro-computed tomography (microCT) scanner (GE Healthcare
Pre-Clinical Imaging, London, ON, Canada). This system features
a high-precision gantry system that rotates the X-ray source and
detector continuously around the anesthetized animal. Scan
protocols are short in duration to limit the radiation dose to the
animals, particularly important in longitudinal studies such as
this. Images were reconstructed at a 45 micron isotropic voxel
size. Histograms were generated to select a global mineralized
tissue threshold that delineated bone from all other tissues.
Geometric and densitometric analyses were performed on a
standardized 3-mm mid-diaphyseal segment in the left femora
of each animal at each time point. The selected bone volume of
interest was analyzed to determine the transverse properties
including, cross-sectional area, cortical thickness, endosteal and
perisoteal perimeters, and bone mineral content. The variables
are schematically illustrated in Fig. 3 and summarized along with
their abbreviations in Table 4.
T-cell subsets
The proportion of peripheral blood CD8 T cells that express high
levels of the memory cell marker CD44 was evaluated in each
mouse at 18 months of age using flow cytometry as described
previously (Jackson et al., 1999; Miller & Chrisp, 2002). This pro-
portion is referred to as the CD8M value in this paper.
Statistical methods
Tabulated average values are shown in tables as mean ± stan-
dard error of the mean. Change scores are calculated by sub-
tracting the value at the earlier age from the value for the later
age, for all mice for which both measurements were available.
Inferences about age effects on each bone measurement, in
specific age intervals, were evaluated by testing the hypothesis
that the corresponding change score was equal to zero. Associa-
tions between predictor values (bone measures, change scores,
T-cell subsets) and survival were evaluated using Cox propor-
tional hazard regression.
Acknowledgments
We thank Liz Burmeister, Sabrina Friedline, and Meenal Mhasker
for animal husbandry assistance, and Kathy Sweet for technical
support in the bone measurement program. This work was sup-
ported by NIA grants AG011687, AG024824 (Pepper Center)
and AG013283 (Shock Center).
Author contributions
Drs Miller and Goldstein designed the study. Ms Kreider con-
ducted the bone scans; she and Dr Goldstein computed mea-
sures of femur dimensions from the raw data sets. Dr Galecki
advised on design and analysis procedures. Dr Miller and
Dr Goldstein wrote the manuscript.
References
Albanes D, Jones DY, Schatzkin A, Micozzi MS, Taylor PR (1988) Adult
stature and risk of cancer. Cancer Res. 48, 1658–1662.
Alexander JM, Bab I, Fish S, Muller R, Uchiyama T, Gronowicz G,
Nahounou M, Zhao Q, White DW, Chorev M, Gazit D, Rosenblatt
M (2001) Human parathyroid hormone 1–34 reverses bone loss in
ovariectomized mice. J. Bone Miner. Res. 16, 1665–1673.
Bonnett BN, Egenvall A, Hedhammar A, Olson P (2005) Mortality in over
350 000 insured Swedish dogs from 1995 to 2000: I. Breed-, gender-,
age- and cause-specific rates. Acta Vet. Scand. 46, 105–120.
Bouxsein ML, Myers KS, Shultz KL, Donahue LR, Rosen CJ, Beamer
WG (2005) Ovariectomy-induced bone loss varies among inbred
strains of mice. J. Bone Miner. Res. 20, 1085–1092.
Brown-Borg HM, Borg KE, Meliska CJ, Bartke A (1996) Dwarf mice
and the ageing process. Nature 384, 33.
Burr DB (2002) Targeted and nontargeted remodeling. Bone 30, 2–4.
Burr DB, Martin RB (1993) Calculating the probability that microcracks
initiate resorption spaces. J. Biomech. 26, 613–616.
Coschigano KT, Clemmons D, Bellush LL, Kopchick JJ (2000) Assess-
ment of growth parameters and life span of GHR ⁄ BP gene-dis-
rupted mice. Endocrinology 141, 2608–2613.
Davey SG, Hart C, Upton M, Hole D, Gillis C, Watt G, Hawthorne V
(2000) Height and risk of death among men and women: aetiologi-
cal implications of associations with cardiorespiratory disease and
cancer mortality. J. Epidemiol. Community Health 54, 97–103.
Eigenmann JE, Patterson DF, Froesch ER (1984) Body size parallels
insulin-like growth factor I levels but not growth hormone secretory
capacity. Acta Endocrinologica 106, 448–453.
Flurkey K and Harrison DE (1990) Use of genetic models to investigate
the hypophyseal regulation of senescence. In Genetic Effects on
Aging II. (Harrison DE, Caldwell NJ, eds). The Telford Press, Chapter
24, pp. 437–456.
Flurkey K, Papaconstantinou J, Miller RA, Harrison DE (2001) Lifespan
extension and delayed immune and collagen aging in mutant mice
with defects in growth hormone production. Proc. Natl Acad. Sci.
USA 98, 6736–6741.
Han ZH, Palnitkar S, Rao DS, Nelson D, Parfitt AM (1997) Effects of
ethnicity and age or menopause on the remodeling and turnover of
iliac bone: implications for mechanisms of bone loss. J. Bone Miner.
Res. 12, 498–508.
Harper JM, Galecki AT, Burke DT, Miller RA (2004) Body weight, hor-
mones and T-cell subsets as predictors of lifespan in genetically het-
erogeneous mice. Mech. Ageing Dev. 125, 381–390.
Heaney RP (2003) Is the paradigm shifting? Bone 33, 457–465.
Hebert PR, Rich-Edwards JW, Manson JE, Ridker PM, Cook NR, O’Con-
nor GT, Buring JE, Hennekens CH (1993) Height and incidence of car-
diovascular disease in male physicians. Circulation 88, 1437–1443.
Femoral change rate predicts mouse lifespan, R. A. Miller et al.
ª 2011 The Authors
Aging Cell ª 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
390
Hoskins JD, McCurnin DM (1997) Geriatric care in the late 1990s. Vet.
Clin. North Am. – Small Anim. Pract. 27, 1273–1284.
Ikeno Y, Bronson RT, Hubbard GB, Lee S, Bartke A (2003) Delayed
occurrence of fatal neoplastic diseases in ames dwarf mice: correla-
tion to extended longevity. J. Gerontol. A Biol. Sci. Med. Sci. 58,
291–296.
Iwaniec UT, Yuan D, Power RA, Wronski TJ (2006) Strain-dependent
variations in the response of cancellous bone to ovariectomy in
mice. J. Bone Miner. Res. 21, 1068–1074.
Jackson AU, Fornes A, Galecki A, Miller RA, Burke DT (1999) Multiple-
trait quantitative trait loci analysis using a large mouse sibship.
Genetics 151, 785–795.
Johnson TE (2006) Recent results: biomarkers of aging. Exp. Gerontol.
41, 1243–1246.
Kinney BA, Meliska CJ, Steger RW, Bartke A (2001) Evidence that
Ames dwarf mice age differently from their normal siblings in
behavioral and learning and memory parameters. Horm. Behav. 39,
277–284.
Li Y, Deeb B, Pendergrass W, Wolf N (1996) Cellular proliferative
capacity and life span in small and large dogs. J. Gerontol. A Biol.
Sci. Med. Sci. 51, B403–B408.
Lipman R, Galecki A, Burke DT, Miller RA (2004) Genetic loci that
influence cause of death in a heterogeneous mouse stock. J. Geron-
tol. Biol. Sci. 59A, 977–983.
Michell AR (1999) Longevity of British breeds of dog and its relation-
ships with sex, size, cardiovascular variables and disease. Vet. Rec.
145, 625–629.
Miller RA (2001a) Biomarkers of aging. Sci. Aging Knowledge. Envi-
ron. 2001, e2.
Miller RA (2001b) Biomarkers of aging: prediction of longevity by
using age-sensitive T-cell subset determinations in a middle-aged,
genetically heterogeneous mouse population. J. Gerontol. A Biol.
Sci. Med. Sci. 56, B180–B186.
Miller RA, Chrisp C (2002) T cell subset patterns that predict resistance
to spontaneous lymphoma, mammary adenocarcinoma, and fibro-
sarcoma in mice. J. Immunol. 169, 1619–1625.
Miller RA, Chrisp C, Galecki A (1997) CD4 memory T cell levels predict
lifespan in genetically heterogeneous mice. FASEB J. 11, 775–783.
Miller RA, Austad S, Burke D, Chrisp C, Dysko R, Galecki A, Monnier
V (1999) Exotic mice as models for aging research: polemic and pro-
spectus. Neurobiol. Aging 20, 217–231.
Miller RA, Chrisp C, Atchley WR (2000) Differential longevity in mouse
stocks selected for early life growth trajectory. J. Gerontol. Biol. Sci.
55A, B455–B461.
Miller RA, Harper JM, Galecki A, Burke DT (2002) Big mice die young:
early-life body weight predicts longevity in genetically heteroge-
neous mice. Aging Cell 1, 22–29.
Miller RA, Jackson AU, Galecki AT, Burke DT (2003) Genetic polymor-
phisms in mouse genes regulating age-sensitive and age-stable T cell
subsets in mice. Genes Immun. 4, 30–39.
Miller RA, Harrison DE, Astle CM, Floyd RA, Flurkey K, Hensley KL,
Javors MA, Leeuwenburgh C, Nelson JF, Ongini E, Nadon NL, War-
ner HR, Strong R (2007) An aging interventions testing program:
study design and interim report. Aging Cell 6, 565–575.
Noble B (2003) Bone microdamage and cell apoptosis. Eur. Cell Mater.
6, 46–55.
Parfitt AM (2002) Targeted and nontargeted bone remodeling: rela-
tionship to basic multicellular unit origination and progression. Bone
30, 5–7.
Patronek GJ, Waters DJ, Glickman LT (1997) Comparative longevity of
pet dogs and humans: implications for gerontology research. J. Ger-
ontol. A Biol. Sci. Med. Sci. 52, B171–B178.
Petrelli JM, Calle EE, Rodriguez C, Thun MJ (2002) Body mass index,
height, and postmenopausal breast cancer mortality in a prospective
cohort of US women. Cancer Causes Control 13, 325–332.
Reeves GM, McCreadie BR, Chen S, Galecki AT, Burke DT, Miller RA,
Goldstein SA (2007) Quantitative trait loci modulate vertebral mor-
phology and mechanical properties in a population of 18-month-old
genetically heterogeneous mice. Bone 40, 433–443.
Sprott RL (1999) Biomarkers of aging. J. Gerontol. Biol. Sci. 54A,
B464–B465.
Tretli S (1989) Height and weight in relation to breast cancer morbid-
ity and mortality. A prospective study of 570 000 women in Nor-
way. Int. J. Cancer 44, 23–30.
Tretli S, Robsahm TE (1999) Height, weight and cancer of the oesoph-
agus and stomach: a follow-up study in Norway. Eur. J. Cancer Prev.
8, 115–122.
Vergara M, Smith-Wheelock M, Harper JM, Sigler R, Miller RA (2004)
Hormone-treated Snell dwarf mice regain fertility but remain long-
lived and disease resistant. J. Gerontol. Biol. Sci. 59, 1244–1250.
Volkman SK, Galecki AT, Burke DT, Paczas MR, Moalli MR, Miller RA,
Goldstein SA (2003) Quantitative trait loci for femoral size and
shape in a genetically heterogeneous mouse population. J. Bone
Miner. Res. 18, 1497–1505.
Volkman SK, Galecki AT, Burke DT, Miller RA, Goldstein SA (2004)
Quantitative trait loci that modulate femoral mechanical properties
in a genetically heterogeneous mouse population. J. Bone Miner.
Res. 19, 1497–1505.
Waldorff EI, Christenson KB, Cooney LA, Goldstein SA (2010) Micro-
damage repair and remodeling requires mechanical loading. J. Bone
Miner. Res. 25, 734–745.
Wang C, Li Q, Redden DT, Weindruch R, Allison DB (2004) Statistical
methods for testing effects on ‘‘maximum lifespan’’. Mech. Ageing
Dev. 125, 629–632.
Williams DL, Heath MF, Wallis C (2004) Prevalence of canine cataract:
preliminary results of a cross-sectional study. Vet. Ophthalmol. 7,
29–35.
Femoral change rate predicts mouse lifespan, R. A. Miller et al.
ª 2011 The Authors
Aging Cell ª 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
391
